世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

米国の女性用緊急避妊薬の市場レポート・予測 2021-2027年

United States Female Emergency Contraceptive Pill Market Report & Forecast 2021-2027

当レポートでは、米国における女性用緊急避妊薬の市場規模および予測を掲載しています。アメリカ合衆国女性用緊急避妊薬市場収益、2016-2021年、2022-2027年、(百万ドル) アメリカ合衆国の女性用緊急避妊薬市... もっと見る

出版社	出版年月	電子版価格	納期	言語
QYResearch QYリサーチ	2021年10月29日	US$3,400 シングルユーザライセンスライセンス・価格情報注文方法はこちら	5-7営業日	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

当レポートでは、米国における女性用緊急避妊薬の市場規模および予測を掲載しています。
アメリカ合衆国女性用緊急避妊薬市場収益、2016-2021年、2022-2027年、(百万ドル)
アメリカ合衆国の女性用緊急避妊薬市場販売数、2016-2021年、2022-2027年、(Kユニット)
米国の女性用緊急避妊薬トップ5企業の2020年の動向(%)
女性用緊急避妊薬の世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに成長すると予想され、2021年から2027年の間にXX％のCAGRで成長すると予想されます。
米国の女性用緊急避妊薬市場は、2020年にXX百万米ドル、2027年にXX百万米ドルに達し、予測期間中にXX％のCAGRで成長すると予測されています。
QYResearchは、女性用緊急避妊薬のメーカー、サプライヤー、流通業者、業界専門家を対象に、売上高、収益、需要、価格変動、製品タイプ、最近の開発・計画、業界動向、ドライバー、課題、障害、潜在的リスクなど、この業界について調査しました。
総市場をセグメント別に見ると
米国女性用緊急避妊薬市場、タイプ別、2016-2021年、2022-2027年（単位：百万ドル）・（Kユニット）
米国女性用緊急避妊薬市場セグメント別割合、タイプ別、2020年(%)
レボノルゲストレル
酢酸ウリプリスタル

米国女性用緊急避妊薬市場、用途別、2016-2021年、2022-2027年（百万ドル）・（Kユニット）
米国女性用緊急避妊薬市場セグメント別割合、アプリケーション別、2020年(%)
オンライン
オフライン

競合他社の分析
当レポートでは、以下のような主要な市場参加者の分析も行っています。
主要企業米国市場における女性用緊急避妊薬の収益、2016-2021年（推定）、（百万ドル）
主要企業の女性用緊急避妊薬の米国市場における収益シェア、2020年(%)
主要企業の米国市場における女性用緊急避妊薬の売上高、2016年～2021年（推定）、（Kユニット）
主要企業の女性用緊急避妊薬の米国市場における販売シェア、2020年(%)
さらに、本レポートでは、市場における競合他社のプロファイルを紹介しています。主なプレイヤーは以下の通りです。
ファウンデーション・コンシューマー・ヘルスケア
Gedeon Richter
Zizhu Pharma
浙江省Xianju Pharma
HRAファーマ
レジェネックス
マンカインド・ファーマ
ピラマル
ルパン
シジー・ヘルスケア
HLLライフケア

ページTOPに戻る

1 Introduction to Research & Analysis Reports
1.1 Female Emergency Contraceptive Pill Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Female Emergency Contraceptive Pill Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Female Emergency Contraceptive Pill Overall Market Size
2.1 United States Female Emergency Contraceptive Pill Market Size: 2021 VS 2027
2.2 United States Female Emergency Contraceptive Pill Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Female Emergency Contraceptive Pill Sales: 2016-2027

3 Company Landscape
3.1 Top Female Emergency Contraceptive Pill Players in United States Market
3.2 Top United States Female Emergency Contraceptive Pill Companies Ranked by Revenue
3.3 United States Female Emergency Contraceptive Pill Revenue by Companies
3.4 United States Female Emergency Contraceptive Pill Sales by Companies
3.5 United States Female Emergency Contraceptive Pill Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Female Emergency Contraceptive Pill Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Female Emergency Contraceptive Pill Product Type
3.8 Tier 1, Tier 2 and Tier 3 Female Emergency Contraceptive Pill Players in United States Market
3.8.1 List of Tier 1 Female Emergency Contraceptive Pill Companies in United States
3.8.2 List of Tier 2 and Tier 3 Female Emergency Contraceptive Pill Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Female Emergency Contraceptive Pill Market Size Markets, 2021 & 2027
4.1.2 Levonorgestrel
4.1.3 Ulipristal Acetate
4.2 By Type - United States Female Emergency Contraceptive Pill Revenue & Forecasts
4.2.1 By Type - United States Female Emergency Contraceptive Pill Revenue, 2016-2021
4.2.2 By Type - United States Female Emergency Contraceptive Pill Revenue, 2022-2027
4.2.3 By Type - United States Female Emergency Contraceptive Pill Revenue Market Share, 2016-2027
4.3 By Type - United States Female Emergency Contraceptive Pill Sales & Forecasts
4.3.1 By Type - United States Female Emergency Contraceptive Pill Sales, 2016-2021
4.3.2 By Type - United States Female Emergency Contraceptive Pill Sales, 2022-2027
4.3.3 By Type - United States Female Emergency Contraceptive Pill Sales Market Share, 2016-2027
4.4 By Type - United States Female Emergency Contraceptive Pill Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Female Emergency Contraceptive Pill Market Size, 2021 & 2027
5.1.2 Online
5.1.3 Offline
5.2 By Application - United States Female Emergency Contraceptive Pill Revenue & Forecasts
5.2.1 By Application - United States Female Emergency Contraceptive Pill Revenue, 2016-2021
5.2.2 By Application - United States Female Emergency Contraceptive Pill Revenue, 2022-2027
5.2.3 By Application - United States Female Emergency Contraceptive Pill Revenue Market Share, 2016-2027
5.3 By Application - United States Female Emergency Contraceptive Pill Sales & Forecasts
5.3.1 By Application - United States Female Emergency Contraceptive Pill Sales, 2016-2021
5.3.2 By Application - United States Female Emergency Contraceptive Pill Sales, 2022-2027
5.3.3 By Application - United States Female Emergency Contraceptive Pill Sales Market Share, 2016-2027
5.4 By Application - United States Female Emergency Contraceptive Pill Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Foundation Consumer Healthcare
6.1.1 Foundation Consumer Healthcare Corporation Information
6.1.2 Foundation Consumer Healthcare Overview
6.1.3 Foundation Consumer Healthcare Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.1.4 Foundation Consumer Healthcare Female Emergency Contraceptive Pill Product Description
6.1.5 Foundation Consumer Healthcare Recent Developments
6.2 Gedeon Richter
6.2.1 Gedeon Richter Corporation Information
6.2.2 Gedeon Richter Overview
6.2.3 Gedeon Richter Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.2.4 Gedeon Richter Female Emergency Contraceptive Pill Product Description
6.2.5 Gedeon Richter Recent Developments
6.3 Zizhu Pharma
6.3.1 Zizhu Pharma Corporation Information
6.3.2 Zizhu Pharma Overview
6.3.3 Zizhu Pharma Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.3.4 Zizhu Pharma Female Emergency Contraceptive Pill Product Description
6.3.5 Zizhu Pharma Recent Developments
6.4 Zhejiang Xianju Pharma
6.4.1 Zhejiang Xianju Pharma Corporation Information
6.4.2 Zhejiang Xianju Pharma Overview
6.4.3 Zhejiang Xianju Pharma Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.4.4 Zhejiang Xianju Pharma Female Emergency Contraceptive Pill Product Description
6.4.5 Zhejiang Xianju Pharma Recent Developments
6.5 HRA Pharma
6.5.1 HRA Pharma Corporation Information
6.5.2 HRA Pharma Overview
6.5.3 HRA Pharma Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.5.4 HRA Pharma Female Emergency Contraceptive Pill Product Description
6.5.5 HRA Pharma Recent Developments
6.6 Regenex
6.6.1 Regenex Corporation Information
6.6.2 Regenex Overview
6.6.3 Regenex Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.6.4 Regenex Female Emergency Contraceptive Pill Product Description
6.6.5 Regenex Recent Developments
6.7 Mankind Pharma
6.7.1 Mankind Pharma Corporation Information
6.7.2 Mankind Pharma Overview
6.7.3 Mankind Pharma Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.7.4 Mankind Pharma Female Emergency Contraceptive Pill Product Description
6.7.5 Mankind Pharma Recent Developments
6.8 Piramal
6.8.1 Piramal Corporation Information
6.8.2 Piramal Overview
6.8.3 Piramal Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.8.4 Piramal Female Emergency Contraceptive Pill Product Description
6.8.5 Piramal Recent Developments
6.9 Lupin
6.9.1 Lupin Corporation Information
6.9.2 Lupin Overview
6.9.3 Lupin Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.9.4 Lupin Female Emergency Contraceptive Pill Product Description
6.9.5 Lupin Recent Developments
6.10 Syzygy Healthcare
6.10.1 Syzygy Healthcare Corporation Information
6.10.2 Syzygy Healthcare Overview
6.10.3 Syzygy Healthcare Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.10.4 Syzygy Healthcare Female Emergency Contraceptive Pill Product Description
6.10.5 Syzygy Healthcare Recent Developments
6.11 HLL Life Care
6.11.1 HLL Life Care Corporation Information
6.11.2 HLL Life Care Overview
6.11.3 HLL Life Care Female Emergency Contraceptive Pill Sales and Revenue in United States Market (2016-2021)
6.11.4 HLL Life Care Female Emergency Contraceptive Pill Product Description
6.11.5 HLL Life Care Recent Developments

7 United States Female Emergency Contraceptive Pill Production Capacity, Analysis
7.1 United States Female Emergency Contraceptive Pill Production Capacity, 2016-2027
7.2 Female Emergency Contraceptive Pill Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Female Emergency Contraceptive Pill Supply Chain Analysis
9.1 Female Emergency Contraceptive Pill Industry Value Chain
9.2 Female Emergency Contraceptive Pill Upstream Market
9.3 Female Emergency Contraceptive Pill Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Female Emergency Contraceptive Pill Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

ページTOPに戻る

Table of Contents

Summary

This report contains market size and forecasts of Female Emergency Contraceptive Pill in United States, including the following market information:
United States Female Emergency Contraceptive Pill Market Revenue, 2016-2021, 2022-2027, ($ millions)
United States Female Emergency Contraceptive Pill Market Sales, 2016-2021, 2022-2027, (K Units)
United States top five Female Emergency Contraceptive Pill companies in 2020 (%)
The global Female Emergency Contraceptive Pill market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The United States Female Emergency Contraceptive Pill market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Female Emergency Contraceptive Pill manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
United States Female Emergency Contraceptive Pill Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Female Emergency Contraceptive Pill Market Segment Percentages, By Type, 2020 (%)
Levonorgestrel
Ulipristal Acetate

United States Female Emergency Contraceptive Pill Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Female Emergency Contraceptive Pill Market Segment Percentages, By Application, 2020 (%)
Online
Offline

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Emergency Contraceptive Pill revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Female Emergency Contraceptive Pill revenues share in United States market, 2020 (%)
Key companies Female Emergency Contraceptive Pill sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Female Emergency Contraceptive Pill sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Foundation Consumer Healthcare
Gedeon Richter
Zizhu Pharma
Zhejiang Xianju Pharma
HRA Pharma
Regenex
Mankind Pharma
Piramal
Lupin
Syzygy Healthcare
HLL Life Care

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630

米国の女性用緊急避妊薬の市場レポート・予測 2021-2027年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート